White Paper | June 19, 2008

White Paper: Regulation 21 CFR Part 210-211

Source: Pilgrim Software Inc.
Regulation21CFRPart210-211
The demand for healthcare products is ever increasing as the landscape of modern society evolves. These trends are reshaping the Pharmaceutical and Biologics industries. With the demand for products, comes the concern among pharma-bio manufacturers for regulatory scrutiny.

For full access to this content, please Register or Sign In.

Access Content White Paper: Regulation 21 CFR Part 210-211